IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BARLOCCO, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.395
NA - Nord America 7.312
AS - Asia 6.941
SA - Sud America 627
AF - Africa 102
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 3
Totale 23.404
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.130
GB - Regno Unito 3.457
SG - Singapore 2.197
CN - Cina 2.028
SE - Svezia 989
IT - Italia 927
RU - Federazione Russa 843
HK - Hong Kong 585
TR - Turchia 535
DE - Germania 526
BR - Brasile 476
VN - Vietnam 450
KR - Corea 373
FR - Francia 354
IE - Irlanda 306
IN - India 298
UA - Ucraina 276
NL - Olanda 252
FI - Finlandia 214
EU - Europa 155
BD - Bangladesh 117
CA - Canada 93
ID - Indonesia 79
JP - Giappone 78
CO - Colombia 57
MX - Messico 57
DK - Danimarca 52
BE - Belgio 35
AR - Argentina 34
IQ - Iraq 31
AT - Austria 27
PH - Filippine 24
GR - Grecia 22
AU - Australia 21
PK - Pakistan 20
TW - Taiwan 19
CI - Costa d'Avorio 18
EC - Ecuador 17
ZA - Sudafrica 17
PL - Polonia 16
MA - Marocco 15
CL - Cile 14
PT - Portogallo 14
SA - Arabia Saudita 14
EG - Egitto 13
ES - Italia 12
KE - Kenya 12
MY - Malesia 12
VE - Venezuela 12
CH - Svizzera 11
HU - Ungheria 11
JO - Giordania 10
PY - Paraguay 10
IR - Iran 9
TN - Tunisia 9
JM - Giamaica 8
UZ - Uzbekistan 8
AZ - Azerbaigian 7
IL - Israele 7
RO - Romania 7
BG - Bulgaria 6
CR - Costa Rica 6
NP - Nepal 6
TH - Thailandia 6
CZ - Repubblica Ceca 5
AE - Emirati Arabi Uniti 4
ET - Etiopia 4
GT - Guatemala 4
LU - Lussemburgo 4
NO - Norvegia 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
DZ - Algeria 3
GE - Georgia 3
LT - Lituania 3
LV - Lettonia 3
PE - Perù 3
AL - Albania 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
IS - Islanda 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MD - Moldavia 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
SN - Senegal 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AO - Angola 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
Totale 23.532
Salva come PNG Salva come JPEG
Città #
Southend 3.289
Singapore 1.184
Chandler 619
Hong Kong 548
Seattle 544
Ashburn 527
Beijing 452
San Jose 435
Princeton 394
Santa Clara 365
Wilmington 326
Milan 316
Dublin 305
Council Bluffs 234
Dallas 234
Ann Arbor 219
Fairfield 212
Redmond 187
Mountain View 179
Woodbridge 163
Lauterbourg 158
Nanjing 147
Los Angeles 143
Sakarya 141
Bengaluru 139
Jacksonville 138
Des Moines 131
Buffalo 121
Moscow 112
Ho Chi Minh City 111
Dearborn 104
Boardman 97
Hanoi 93
Houston 84
Guangzhou 78
Cambridge 72
Hefei 71
Shanghai 66
Andover 60
Somerville 58
Hangzhou 54
Shenyang 52
Tianjin 51
Bogotá 50
The Dalles 49
Columbus 47
Tokyo 47
Cangzhou 46
Eitensheim 46
Frankfurt am Main 44
Jinan 43
Munich 43
Nanchang 43
New York 43
Seoul 43
Serra 38
Helsinki 37
Medford 36
Redwood City 36
Phoenix 35
Sunnyvale 34
São Paulo 34
Shenzhen 33
Dong Ket 32
Fuzhou 32
Hebei 32
Delhi 31
Jiaxing 31
Brussels 30
Changsha 29
Jakarta 29
Grafing 28
Zhengzhou 27
Chicago 26
Haiphong 25
Istanbul 25
Wuhan 24
Da Nang 23
Kent 23
Rome 23
Toronto 22
Hamburg 20
Nuremberg 19
San Diego 19
Ottawa 18
Abidjan 17
Athens 17
Berlin 17
Turin 17
Belo Horizonte 16
London 16
Montreal 16
Venezia 16
Boston 15
Ningbo 15
Orem 15
Vienna 15
Redondo Beach 14
Yeoncheon-gun 14
Dongguan 13
Totale 14.641
Salva come PNG Salva come JPEG
Nome #
An in vivo active 1,2,5-oxadiazole Pt(II) complex : a promising anticancer agent endowed with STAT3 inhibitory properties 421
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest 414
Synthesis, structure–activity relationships andstereochemical investigations of new tricyclic pyridazinone derivatives as potential STAT3 inhibitors 367
Discovery and development of novel salicylate synthase (MbtI) Furanic inhibitors as antitubercular agents 357
Modeling, synthesis and NMR characterization of novel chimera compounds targeting STAT3 306
Muraglitazar Bristol-Myers Squibb/Merck 284
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 262
Biological and computational evaluation of an oxadiazole derivative (MD77) as a new lead for direct STAT3 inhibitors 242
New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI) : Preliminary Biological Evaluation and Molecular Modeling Studies 212
Signal transducer and activator of transcription (Stat) 3: a promising target for anticancer therapy 211
New inhibitors of salicylate synthase (MbtI) from m. tubercolosis: a promising strategy to antitubercular drugs 211
A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activity 211
Synthesis, structure-activity relationships and stereochemical investigations on new tricyclic pyridazinone derivatives as potential STAT3 inhibitors 204
6-Chloropyridazin-3-yl-derivatives active as nicotinic agents: synthesis, binding, and modeling studies 202
Structural and conformational studies of 3,8-diazabyciclo[3.2.1]octane derivatives, selective agonists of µ-opioid receptors 200
Synthesis, modeling, and crystallographic study of 3,4-disubstituted-1,2,5-oxadiazoles and evaluation of their ability to decrease STAT3 activity 198
Studies on potential STAT-3 inhibitors: reactivity and behaviour of furazan derivatives 198
Antibacterial agent discovery using thymidylate synthase biolibrary screening 197
A structural and conformational study of 8-p-nitrocinnamyl-3-propionyl-3,8-diazabicyclo[3.2.1]-octane, selective agonist of μ-opioid receptors 196
3,8-diazabicyclo[3.2.1]octane derivatives as analogues of abasilide, a class III antiarrhythmic agent 192
Ureido-pyridazinone derivatives : insights into the structural and conformational properties for STAT3 inhibition 188
Merged structures as new STAT3 inhibitors: the chimera compounds 187
Challenges in the design of multitarget drugs against multifactorial pathologies: a new life for medicinal chemistry? 181
STAT3 direct inhibitors: from MD77 to AC33 180
Thymidylate synthase structure, function and implication in drug discovery 176
Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1 : recent developments concerning substrates and inhibitors of a promising therapeutic target 174
6-Chloropyridazin-3yl derivatives active as nicotinic agents: X-ray structures of [3-(6- Chloropyridazin-3yl)-N,N-dimethylpiperazine]I (1) and [3-(6-Chloropyridazin-3yl)-N,N-dimethylhomopiperazine]I (2) 173
5,6-dinitrophenyl and 5-aminophenyl-6-nitrophenyl analogues of the ACAT inhibitor 5,6-diphenyl-3-alkylaminopyridazines 172
An oxadiazole Pt(II) complex with promising in vivo antitumor activity 172
3-Heptylamino-5-Phenylpyridazine Derivatives as Analogues of the Acyl-CoA:Cholesterol Acyltransferase Inhibitors Containing the N-Heptyl-N-Arylureidic moiety 171
Development on furazan derivatives as potential STAT-3 inhibitors 169
An HTS FP assay able to selectively identify STAT3-DBD inhibitors 168
Design, synthesis and biological evaluation of novel antitubercular agents targeting the Salycilate Syntase (MbtI). 168
Privileged structures as leads in medicinal chemistry 166
2,2,6- and 2,3,5-trimethylpiperazines as monocyclic analogues of the mu-opioid agonist 3,8-diazabicyclo[3.2.1]octanes: Synthesis, modeling, and activity 166
Oxadiazole Pt(II) complexes: promising STAT3 inhibitors in cancer therapy 164
2,2,6- and 2,3,5-trimethypiperazines as monocyclic analogues of the mu-opioid agonis 3,8-diazabicyclo[3.2.1]octanes: synthesis, modeling and activity 162
A series of diarylsubstituted oximes as potential substrate for new aldose reductase inhibitors 160
Spirocyclopropane carboxylic acids derived from 1-tetralone and 4-chromanone and their conversion to the corresponding pyridazinones 159
Mono- or Diphenylpyridazines Connected to N-(2,4-Difluorophenyl)-N'-heptylurea as Acyl-CoA:Cholesterol Acyltransferase Inhibitors 158
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: Synthesis, activity, and modeling 158
Ureidopyridazine derivatives as acyl-CoA:cholesterol acyltransferase inhibitors 157
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor 157
Structure-based design of inhibitors specific for bacterial thymidylate synthase 157
Biphenyl versus phenylpyridazine derivatives : the role of the heterocycle in a series of acyl-CoA : cholesterol acyl transferase inhibitors 156
X-ray structure and chemical behaviour of three oxadiazole derivatives, as potential Stat3 inhibitors 156
Tricyclic Pyridazinone derivatives : development of new STAT-3 inhibitors 156
New Platinum(II) complexes in STAT3 inhibition: a promising tool for anticancer therapy 156
Special Issue: Frontiers in Antimicrobial Drug Discovery and Design 155
Identification of a novel STAT3 inhibitor structurally related to the oxadiazole derivative MD77 153
A new heterocyclic class: 2,5,6-trisubstituted-6,7-dihydro-1,3,4-oxadiazepines: A facile and general synthesis 152
Rigid congeners of arylpyridazinones. IV. Synthesis and activity of derivatives of the new heterocyclic system 9H-indeno[2,1-c]pyridazine 151
Optimation of the lead MD77 151
Synthesis, activity and molecular modeling of a mew series of tricyclic pyridazinones as selective aldose reductase inhibitors 148
Ghrelin receptor modulators : a patent review (2011 -- 2014) 148
Exploring scaffolds to discover new STAT3 inhibitors, as novel anticancer agents. 148
Sintesi, attività e modelling di derivati mono- e difenilpiridazinici come potenziali inibitori dell'enzima acil-CoA colesterolo aciltrasferasi (ACAT) 147
Pyridazinones and their tricyclic congeners : chemistry and biology 147
2-(Substituted)amino-2,8-diazaspiro[4,5]decan-1,3-diones as potential muscarinic agonists: Synthesis, modeling and binding studies 147
5,6-diphenylpyridazine derivatives as acyl-CoA:cholesterol acyltransferase inhibitors 146
New congeners of antihypertensive and antithrombotic 7-amino or acetylamino substituted-4,4a-dihydro5H-indeno(1,2-c)pyridazin-3-ones 146
A novel antifungal anthraquinone from Saprosma fragrans 144
Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors 142
Benzo(c)thiophene derivatives. IV. Synthesis and disproportionation of 1,1',3,3'-tetrahydro-1,1'-dimethoxycarbonyl-1,1'-dibenzo(c)thiophene 142
Congo red analogues as potential anti-prion agents 142
Iron acquisition pathways as targets for antitubercular drugs 142
Neuronal nicotinic acetylcholine receptor agonists 140
Exploring the replacement of the pyridazine ring in the search for new ACAT inhibitors 140
Synthesis and pharmacological evaluation of 4,4a-dihydro-5H(1)benzopyrano(4,3-c)pyridazin-3(2H)ones bioisosters of antihypertensive and antithrombotic benzo(h)cinnolinones 140
Docking of 6-chloropyridazin-3-yl derivatives active on nicotinic acetylcholine receptors into molluscan Acetylcholine Binding Protein 139
New STAT3 inhibitors: identification of a lead 139
Disegno di farmaci attraverso inibizione enzimatica 137
Proprietà fisicochimiche e biofarmaceutiche dei farmaci e farmacocinetica 137
Some aspects of pharmaceutical research in Italian universities. Participants, topics, financing, and intellectual property 136
Studies on benzylamino derivatives as potential SSAO inhibitors 136
Biotecnolgie farmaceutiche 136
Pramlintide (Amylin) 135
Antiamnesic activity of the nicotinic agonist DBO-83 in mice 134
Benzocondensed derivatives as rigid analogues of the -opioid agonist 3(8)-cinnamyl-8(3)-propionyl-3,8-diazabicyclo[3.2.1]octanes: synthesis, modeling, and affinity 134
A facile synthesis of 3-aryl-4-pyrazole acetic acids and of their 4,5-dihydro derivatives 133
Conformationally restricted congeners of hypothensive and platelet aggregation inhibitors 6-aryl-5-methyl-4,5-dihydro-3(2H)pyridazinones derived from 5H-indeno(1,2-c)pyridazine 133
Unexpected behaviour of the oxidizing agent sodium m-nitrobenzene sulfonate: synthesis of a new class of 5-hydroxy(1)benzopyrano4,3-cpyridazin-3(2H)ones 132
Discovering new scaffold to build ACAT inhibitors 131
Solid-phase convergent synthesis of a benzoimidazolone library via the combination of two smaller arrays of carboxylic acids and secondary amines 130
MONOCYCLIC ANALOGS OF THE MU-OPIOID AGONIST 3,8-DIAZABICYCLO-[3.2.1]OCTANES - SYNTHESIS, MODELING, AND ACTIVITY 130
Synthesis and pharmacological evaluation of a new series of substituted benzoyl-gamma-butyrolactone derivatives 130
Disegno di farmaci attraverso inibizione enzimatica 130
Interaction of 3,8-diazabicyclo (3.2.1) octanes with mu and delta opioid receptors 128
4,5-Functionalized 6-phenyl-3(2H)pyridazinones: synthesis and evaluation of antinociceptive activity 128
Proprietà fisicochimiche e biofarmaceutiche dei farmaci e farmacocinetica 127
Structural and conformational studies of 3,8-diazabicyclo[3.2.1]octane derivatives, selective agonists of mu-opioid recepors 127
Sintesi ed attivita' diuretica di composti strutturalmente correlabili alla clopamide 127
Pyridazine derivatives as novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors 126
Versatility of the pyridazine system: Chemistry and biology 126
Synthesis and pharmacological evaluation of a new series of substituted benzoyl-γ-butyrolactone derivatives 126
Inquinamento acustico, problema socio-sanitario di rilevanza mondiale. II parte 124
Synthesis and pharmacological evaluation of a new class of 2-oxo-8-azaspiro(4,5)decan-1-ones as analogues of the muscarinic agonist RS-86 123
Hydroxymethylation of 2-hydroxypropiophenones in aqueous medium. Synthesis of 3-hydroxymethyl-3-methyl-4-chromanones and their conversion to 3-methyl-4-chromanone-3-acetic acids 123
Synthesis and pharmacological study of 5-aryl-6-methyl-pyridazin-3(2H)ones and related 5-aryl-6-methylpyridazin-3(2H)ones 122
Conformationally constrained congeners of 6-aryl-5-methyl-4,5-dihydro-3(2H)-pyridazinones active on the cardiovascular system: conformational studies by molecular mechanics calculations and proton NMR spectroscopy 122
Totale 16.864
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.175
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021642 0 0 0 0 0 0 0 0 0 0 509 133
2021/20221.456 164 37 25 49 147 90 116 80 70 127 201 350
2022/20232.235 321 188 170 281 288 465 71 114 200 14 92 31
2023/20241.151 38 111 80 48 199 70 86 101 15 92 135 176
2024/20253.153 123 246 36 290 481 114 127 395 166 214 264 697
2025/20265.768 557 323 707 477 578 417 625 439 768 499 378 0
Totale 24.925